Skip to main content

Avacincaptad pegol ophthalmic Side Effects

Medically reviewed by Drugs.com. Last updated on Sep 8, 2023.

Applies to avacincaptad pegol ophthalmic: intraocular solution.

Serious side effects

Along with its needed effects, avacincaptad pegol ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking avacincaptad pegol ophthalmic:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to avacincaptad pegol ophthalmic: intravitreal solution.

General

The most frequently reported side effects included conjunctival hemorrhage (13%), increased intraocular pressure (IOP) (9%), blurred vision (8%) and neovascular age-related macular degeneration (7%).[Ref]

Ocular

Very common (10% or more): Conjunctival hemorrhage (13%)

Common (1% to 10%): Increased intraocular pressure, blurred vision, choroidal neovascularization, eye pain, vitreous floaters, blepharitis

Frequency not reported: Ocular infection, periocular infection, active intraocular inflammation, endophthalmitis, retinal detachments, neovascular AMD[Ref]

Blurred vision includes visual impairment, blurred vision, reduced visual acuity, and transiently reduced visual acuity.[Ref]

References

1. Product Information. Izervay (avacincaptad pegol). IVERIC Bio, Inc. 2023.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.